SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Ryberg A)
 

Sökning: WFRF:(Ryberg A) > (2020-2024) > Optimising urinary ...

Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.

Matser, Yvette A H (författare)
Verly, Iedan R N (författare)
van der Ham, Maria (författare)
visa fler...
de Sain-van der Velden, Monique G M (författare)
Verhoeven-Duif, Nanda M (författare)
Ash, Shifra (författare)
Cangemi, Giuliana (författare)
Barco, Sebastiano (författare)
Popovic, Maja Beck (författare)
van Kuilenburg, André B P (författare)
Tytgat, Godelieve A M (författare)
Ryberg, Henrik, 1971 (författare)
Gothenburg University,Göteborgs universitet,Centre for Bone and Arthritis Research,Institutionen för medicin, avdelningen för invärtesmedicin och klinisk nutrition,Institute of Medicine, Department of Internal Medicine and Clinical Nutrition
visa färre...
 (creator_code:org_t)
2023
2023
Engelska.
Ingår i: Pediatric blood & cancer. - 1545-5017. ; 70:6
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • The analysis of urinary catecholamine metabolites is a cornerstone of neuroblastoma diagnostics. Currently, there is no consensus regarding the sampling method, and variable combinations of catecholamine metabolites are being used. We investigated if spot urine samples can be reliably used for analysis of a panel of catecholamine metabolites for the diagnosis of neuroblastoma.Twenty-four-hour urine or spot urine samples were collected from patients with and without neuroblastoma at diagnosis. Homovanillic acid (HVA), vanillylmandelic acid (VMA), dopamine, 3-methoxytyramine, norepinephrine, normetanephrine, epinephrine and metanephrine were measured by high-performance liquid chromatography coupled with fluorescence detection (HPLC-FD) and/or ultra-performance liquid chromatography coupled with electrospray tandem mass spectrometry (UPLC-MS/MS).Catecholamine metabolite levels were measured in urine samples of 400 neuroblastoma patients (24-hour urine, n = 234; spot urine, n = 166) and 571 controls (all spot urine). Excretion levels of catecholamine metabolites and the diagnostic sensitivity for each metabolite were similar in 24-hour urine and spot urine samples (p > .08 and >.27 for all metabolites). The area under the receiver-operating-characteristic curve (AUC) of the panel containing all eight catecholamine metabolites was significantly higher compared to that of only HVA and VMA (AUC = 0.952 vs. 0.920, p = .02). No differences were observed in metabolite levels between the two analysis methods.Catecholamine metabolites in spot urine and 24-hour urine resulted in similar diagnostic sensitivities. The Catecholamine Working Group recommends the implementation of spot urine as standard of care. The panel of eight catecholamine metabolites has superior diagnostic accuracy over VMA and HVA.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

Nyckelord

Humans
Chromatography
Liquid
methods
Tandem Mass Spectrometry
methods
Homovanillic Acid
urine
Metanephrine
urine
Vanilmandelic Acid
urine
Neuroblastoma
diagnosis

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy